Literature DB >> 16722648

Comparison between 5,10,15,20-tetraaryl- and 5,15-diarylporphyrins as photosensitizers: synthesis, photodynamic activity, and quantitative structure-activity relationship modeling.

Stefano Banfi1, Enrico Caruso, Loredana Buccafurni, Roberto Murano, Elena Monti, Marzia Gariboldi, Ester Papa, Paola Gramatica.   

Abstract

The synthesis of a panel of seven nonsymmetric 5,10,15,20-tetraarylporphyrins, 13 symmetric and nonsymmetric 5,15-diarylporphyrins, and one 5,15-diarylchlorin is described. In vitro photodynamic activities on HCT116 human colon adenocarcinoma cells were evaluated by standard cytotoxicity assays. A predictive quantitative structure-activity relationship (QSAR) regression model, based on theoretical holistic molecular descriptors, of a series of 34 tetrapyrrolic photosensitizers (PSs), including the 24 compounds synthesized in this work, was developed to describe the relationship between structural features and photodynamic activity. The present study demonstrates that structural features significantly influence the photodynamic activity of tetrapyrrolic derivatives: diaryl compounds were more active with respect to the tetraarylporphyrins, and among the diaryl derivatives, hydroxy-substituted compounds were more effective than the corresponding methoxy-substituted ones. Furthermore, three monoarylporphyrins, isolated as byproducts during diarylporphyrin synthesis, were considered for both photodynamic and QSAR studies; surprisingly they were found to be particularly active photosensitizers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16722648     DOI: 10.1021/jm050997m

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Molecular modeling on structure-function analysis of human progesterone receptor modulators.

Authors:  Ria Pal; Md Ataul Islam; Tabassum Hossain; Achintya Saha
Journal:  Sci Pharm       Date:  2011-06-30

2.  The biological activities of 5,15-diaryl-10,20-dihalogeno porphyrins for photodynamic therapy.

Authors:  Man Yi Li; Le Mi; Gennady Meerovich; Thin Wut Soe; Ting Chen; Ni Ni Than; Yi Jia Yan; Zhi Long Chen
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-06       Impact factor: 4.322

3.  Synthesis of 5,15-diaryltetrabenzoporphyrins.

Authors:  Mikhail A Filatov; Artem Y Lebedev; Sergei A Vinogradov; Andrei V Cheprakov
Journal:  J Org Chem       Date:  2008-05-02       Impact factor: 4.354

4.  Unique diagnostic and therapeutic roles of porphyrins and phthalocyanines in photodynamic therapy, imaging and theranostics.

Authors:  Leanne B Josefsen; Ross W Boyle
Journal:  Theranostics       Date:  2012-10-04       Impact factor: 11.556

5.  Validation of quantitative structure-activity relationship (QSAR) model for photosensitizer activity prediction.

Authors:  Neni Frimayanti; Mun Li Yam; Hong Boon Lee; Rozana Othman; Sharifuddin M Zain; Noorsaadah Abd Rahman
Journal:  Int J Mol Sci       Date:  2011-11-29       Impact factor: 5.923

6.  A new porphyrin for the preparation of functionalized water-soluble gold nanoparticles with low intrinsic toxicity.

Authors:  Oriol Penon; Tania Patiño; Lleonard Barrios; Carme Nogués; David B Amabilino; Klaus Wurst; Lluïsa Pérez-García
Journal:  ChemistryOpen       Date:  2014-12-01       Impact factor: 2.911

Review 7.  Application of TD-DFT Theory to Studying Porphyrinoid-Based Photosensitizers for Photodynamic Therapy: A Review.

Authors:  Agnieszka Drzewiecka-Matuszek; Dorota Rutkowska-Zbik
Journal:  Molecules       Date:  2021-11-26       Impact factor: 4.411

Review 8.  BODIPYs in PDT: A Journey through the Most Interesting Molecules Produced in the Last 10 Years.

Authors:  Miryam Chiara Malacarne; Marzia Bruna Gariboldi; Enrico Caruso
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

9.  In Silico HCT116 Human Colon Cancer Cell-Based Models En Route to the Discovery of Lead-Like Anticancer Drugs.

Authors:  Sara Cruz; Sofia E Gomes; Pedro M Borralho; Cecília M P Rodrigues; Susana P Gaudêncio; Florbela Pereira
Journal:  Biomolecules       Date:  2018-07-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.